SCHEMBL26108174

SCHEMBL26108174

C=CC(=O)N1CCN(c2nccnc2C(=O)c2ccc(C(F)(F)F)nc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.41
▸ HTR1D P28221 1/20 0.41
▸ HTR1B P28222 1/20 0.41
▸ BTK Q06187 2/20 0.39
▸ HSD11B1 P28845 1/20 0.39
▸ F13A1 P00488 1/20 0.38
▸ TGM2 P21980 1/20 0.38
▸ TGM1 P22735 1/20 0.38
▸ TRPV1 Q8NER1 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ CCNK O75909 1/20 0.36
▸ CDK12 Q9NYV4 1/20 0.36
▸ KRAS P01116 5/20 0.36
▸ GAA P10253 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ SLC6A7 Q99884 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ ABL1 P00519 1/20 0.35
▸ BCR P11274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30591869 1.00 HTR1A (0.41) HTR1AHTR1DHTR1BBTKHSD11B1
SCHEMBL26496957 0.92 BTK (0.42) HTR1AHTR1DHTR1BBTKHSD11B1
SCHEMBL30591611 0.86 SLC6A7 (0.46) BTKHSD11B1TRPV1SLC6A7ABL1
SCHEMBL26105642 0.86 SLC6A7 (0.46) BTKHSD11B1TRPV1SLC6A7ABL1
SCHEMBL26105982 0.85 HSD11B1 (0.44) HTR1AHTR1DHTR1BBTKHSD11B1
SCHEMBL30591753 0.85 HSD11B1 (0.44) HTR1AHTR1DHTR1BBTKHSD11B1
SCHEMBL26107989 0.81 HTR1A (0.40) HTR1AHTR1DHTR1BHSD11B1F13A1
SCHEMBL31474450 0.78 KIT (0.39) HSD11B1F13A1TGM2TGM1TRPV1
SCHEMBL30591660 0.78 TRPV1 (0.41) BTKF13A1TGM2TGM1TRPV1
SCHEMBL26104463 0.78 TRPV1 (0.41) BTKF13A1TGM2TGM1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE 2025-06-26 — — US claimed
WO-2023183768-A2 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE (US) 2023-09-28 — — WO claimed
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS THE SCRIPPS RESEARCH INSTITUTE 2025-06-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250206722-A1 SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS YAP1, TEAD1, TEAD2 HTR1A 4543/4885HTR1D 4498/4885HTR1B 4690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback